The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF).

MLA

Ghali JK, et al. “The Influence of Renal Function on Clinical Outcome and Response to Beta-Blockade in Systolic Heart Failure: Insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF).” Journal of Cardiac Failure, vol. 15, no. 4, May 2009, pp. 310–18. EBSCOhost, https://doi.org/10.1016/j.cardfail.2008.11.003.

APA

Ghali JK, Wikstrand J, Van Veldhuisen DJ, Fagerberg B, Goldstein S, Hjalmarson A, Johansson P, Kjekshus J, Ohlsson L, Samuelsson O, Waagstein F, Wedel H, MERIT-HF Study Group, Ghali, J. K., Wikstrand, J., Van Veldhuisen, D. J., Fagerberg, B., Goldstein, S., Hjalmarson, A., & Johansson, P. (2009). The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF). Journal of Cardiac Failure, 15(4), 310–318. https://doi.org/10.1016/j.cardfail.2008.11.003

Chicago

Ghali JK, Wikstrand J, Van Veldhuisen DJ, Fagerberg B, Goldstein S, Hjalmarson A, Johansson P, et al. 2009. “The Influence of Renal Function on Clinical Outcome and Response to Beta-Blockade in Systolic Heart Failure: Insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF).” Journal of Cardiac Failure 15 (4): 310–18. doi:10.1016/j.cardfail.2008.11.003.